Ed Simcox
Private Equity Investor bei Mayo Clinic Platform
Profil
Ed Simcox is currently a Strategic Advisor at Oisin Biotechnologies, Inc., Vice President at Mayo Clinic Platform, and Strategic Advisor & Chief Strategy Officer at Lifeomic Holdings LLC.
Previously, he was a Director at AT&T, Inc. from 2010 to 2014 and Director & Chief Technology Officer at University Health, Inc. from 2006 to 2010.
Mr. Simcox received his undergraduate degree from DePauw University in 1993 and his graduate degree from Robert H.
Mckinney School of Law in 1997.
Aktive Positionen von Ed Simcox
Unternehmen | Position | Beginn |
---|---|---|
Mayo Clinic Platform
Mayo Clinic Platform Investment ManagersFinance Mayo Clinic Platform (Mayo Clinic) is a venture capital firm subsidiary of Mayo Clinic founded in 2019. The firm is headquartered in Rochester, Minnesota. | Private Equity Investor | 01.11.2021 |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Berater | 01.04.2020 |
Ehemalige bekannte Positionen von Ed Simcox
Unternehmen | Position | Ende |
---|---|---|
AT&T INC. | Direktor/Vorstandsmitglied | 01.01.2014 |
University Health, Inc. | Direktor/Vorstandsmitglied | 01.08.2010 |
Ausbildung von Ed Simcox
Robert H. Mckinney School of Law | Graduate Degree |
DePauw University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AT&T INC. | Communications |
Private Unternehmen | 3 |
---|---|
Mayo Clinic Platform
Mayo Clinic Platform Investment ManagersFinance Mayo Clinic Platform (Mayo Clinic) is a venture capital firm subsidiary of Mayo Clinic founded in 2019. The firm is headquartered in Rochester, Minnesota. | Finance |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
University Health, Inc. |